Pediatr. praxi. 2013;14(3):170-172

Dermatomycoses in childhood, diagnostics and therapy

doc.MUDr.Magdalena Skořepová, CSc.
Centrum pro dermatomykózy
Dermatovenerologická klinika 1. LF UK a VFN v Praze

The issues of skin and mucosal mycoses in children differ from those in adults. Onychomycosis, a frequent disease in adults, is rare in

childhood. The incidence of tinea pedis increases with age, being high in puberty and later. Tinea corporis in our country is caused

mainly by zoophilic dermatophytes such as Microsporum canis and Trichophyton mentagrophytes. Tinea capitis is a dermatophytosis

specific for children.

Keywords: dermatophytoses, candidoses, differential diagnosis

Published: July 15, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Skořepová M. Dermatomycoses in childhood, diagnostics and therapy. Pediatr. praxi. 2013;14(3):170-172.
Download citation

References

  1. Dhondt F, Ninane J, De Beule K, et al. Oral candidosis: treatment with absorbable and non-absorbable antifungal agents in children. Mycoses 1992; 35(1-2): 1-8. Go to original source... Go to PubMed...
  2. Novelli V, Holzel H. Safety and tolerability of fluconazole in children. Antimicrob Agents Chemother. 1999; 43(8): 1955-1960. Go to original source... Go to PubMed...
  3. Groll AH, Wood L, Roden M, et al. Safety, Pharmacokinetics, and Pharmacodynamics of Cyclodextrin Itraconazole in Pediatric Patients with Oropharyngeal Candidiasis. Antimicrob Agents Chemother. 2002; 46(8): 2554-2563. Go to original source... Go to PubMed...
  4. McManus BA, McGovern E, Moran GP, et al. Microbiological screening of Irish patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy reveals persistence of Candida albicans strains, gradual reduction in susceptibility to azoles, and incidences of clinical signs of oral candidiasis without culture evidence. J Clin Microbiol. 2011; 49(5): 1879-1889. Go to original source... Go to PubMed...
  5. Borkowski S. Diaper rash care and management. Pediatr Nurs 2004; 30(6): 467-470. Go to PubMed...
  6. Eyerich K, Eyerich S, Hiller J, et al. Chronic mucocutaneous candidiasis, from bench to bedside. Eur J Dermatol 2010; 20(3): 260-265. Go to original source... Go to PubMed...
  7. Andrews MD, Burns M. Common Tinea Infections in Children. Am Fam Physician. 2008; 77(10): 1415-1420. Go to PubMed...
  8. Aghamirian MR, Ghiasian SA. A clinico-epidemiological study on tinea gladiatorum in Iranian wrestlers and mat contamination by dermatophytes. Mycoses 2011; 54(3): 248-253. Go to original source... Go to PubMed...
  9. Pérez-González M, Torres-Rodríguez JM, Martínez-Roig A, et al. Prevalence of tinea pedis, tinea unguium of toenails and tinea capitis in schoolchildren from Barcelona. Rev Iberoam Micol. 2009; 26(4): 228-232. Go to original source... Go to PubMed...
  10. Ginter-Hanselmayer G, Weger W, Smolle J. Onychomycosis: A new emerging infectious disease in childhood population a adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients. J Eur Acad Dermatol Venereol. 2008; 22(4): 470-475. Go to original source... Go to PubMed...
  11. Iglesias A, Tamayo L, Sosa-de-Martínez C, et al. Prevalence and nature of nail alterations in pediatric patients. Pediatr Dermatol. 2001; 18(2): 107-109. Go to original source... Go to PubMed...
  12. Gibbon KL, Goldsmith P, Salisbury JA, et al. Unnecessary surgical treatment of fungal kerions in children. BMJ 2000; 320(7236): 696-697. Go to original source... Go to PubMed...
  13. Bennassar A, Grimalt R. Management of tinea capitis in childhood. Clinical, Cosmetic and Investigational Dermatology 2010; 3(7): 89-98. Go to original source... Go to PubMed...
  14. LC Fuller, FJ Child, G Midgley, et al. Diagnosis and management of scalp ringworm. BMJ 2003; 326(7388): 539-541. Go to original source... Go to PubMed...
  15. Elewski BE, Cáceres HW, DeLeon L, et al. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials. J Am Acad Dermatol. 2008; 59(1): 41-54. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.